Harvest Declares Big Pharma Split Corp. June 2025 Distributions
OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp.... Read more.
Harvest ETFs Announces June 2025 Distributions
OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs for the... Read more.
Digital Transformation Market Industry Trends and Future Forecast to 2035: Market to Surge from USD 1.42 Trillion to USD 13.26 Trillion by 2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Digital Transformation Market Industry Trend and Future Forecast to 2035: Distribution by Type of Technology, Type... Read more.
SOX & Internal Controls Update Training Course 2025: Optimize ICFR Efforts with Latest Best Practices and Technology Considerations (ONLINE EVENT: July 15-16, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “SOX & Internal Controls Update 2025” conference has been added to ResearchAndMarkets.com’s offering.... Read more.
IonQ to Participate in Quantum Korea 2025 and Support Quantum Hackathon for Emerging Talent
IonQ executives to present the company’s updated technology roadmap and highlight strategic collaborations in South Korea COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ... Read more.
Decks & Docks Company Partners with Midwest-Based The Deck Supply
Acquisition of Leading Deck Supplies Distributor Advances Decks & Docks’ Growth as a Specialty Distribution Business CLEARWATER, Fla. & KANSAS CITY, Mo.–(BUSINESS... Read more.
Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries
MALVERN, Pa. & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter... Read more.
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) lesion site Evidence of retinal structural... Read more.
United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
Ralinepag has the potential to be the first once-a-day oral prostacyclin agonist for patients with pulmonary arterial hypertension ADVANCE OUTCOMES will continue... Read more.
Juicy Couture Expands Beauty Offerings with Centric Brands Partnership
New collection of cruelty-free Juicy Couture beauty and bath products to launch across U.S. and Canada NEW YORK–(BUSINESS WIRE)–#centricbrands–Juicy... Read more.